Cyclooxygenase-2 expression as a prognostic factor in sporadic colorectal cancer;Estudio de la expresión de ciclooxigenasa-2 como factor pronóstico en el cáncer colorrectal esporádico

Cirugia Espanola

Volumn 78, Issue 1, 2005, Pages 39-44

  Jiménez Anula, D Juan ^a   Luque, Rafael J ^a   Gaforio, José J ^b   Delgado, Miguel ^b  

^a Hospital Universitario Medico Quirurgico   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Prognostic factor

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER STAGING; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; METABOLISM; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33644863343     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(05)70882-4     Document Type: Article

References (22)

1. Eberhart CH, DuBois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology. 1995;109:285-301.
2. Willians CW, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol. 1996;270:G393-400.
3. Masunaga R, Kohno H, Dhar DK, Shibakita M, Kinugasa S, Yoshimura H. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res. 2000;6:4064-8.
4. Takahashi M, Fukutake M, Yokota S, Ishida K, Wakabayashi K, Sugimura T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J Cancer Res. 1996;122:219-22.
5. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey R, Morrow J. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest. 1997;99:2254-9.
6. Tomozawa S, Nagawa H, Tsuno H, Hatano K, Osada T, Kitayama J. Inhibition of haematogenous metastasis of colon cancer in mice by a selective cox-2 inhibitor, JTE-522. Br J Cancer. 1999;81:1274-9.
7. Nagatsuka I, Yamada N, Shimizu S, Ohira M, Nishino H, Seki S. Inhibitory effects of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Int J Cancer. 2002;100:515-9.
8. Pugh S, Thomas GA. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut. 1994;35:675-8.
9. Konno H, Baba M, Shoji T, Ohta M, Suzuki S, Nakamura S. Cyclooxygenase- 2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin Exp Metastasis. 2002;19:527-34.
10. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukau S, Asai K. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55:3785-9.
11. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer. 2000;3:324-8.
12. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Ishii Y, Kabeshima Y. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum. 2002;45:98-103.
13. Sheehan K, Sheahan K, O'Donoghue D, McSweeney F, Conroy R, Fitzgeral D. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999;282:1254-7.
14. Maekawa M, Sugano K, Sano H, Miyazaki S, Ushiama M, Fujita S. Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps. Jpn J Clin Oncol. 1998;2:421-31.
15. Eberhart CE, Coffey RJ, Radica A, Giardello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology. 1994;107:1183-8.
16. Dimberg J, Samuelsson A, Hugande A, Söderkvist P. Differential expression of cyclooxygenase-2 in human colorectal cancer. Gut. 1999;45:730-2.
17. Gustafson-Svärd C, Lilja I, Hallböök O, Sjödahl R. Cyclooxygenase- 1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut. 1996;38:79-84.
18. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol. 1999;187:295-301.
19. Petersen S, Haroske G, Hellmich G, Ludwing K, Petersen C, Eicheler W. COX-2 expression in rectal carcinoma: inmunohistochemical pattern and clinical outcome. Anticancer Res. 2002;22:1225-30.
20. Joo YE, Kim HS, Min SW, Lee WS, Park SH, Park CS. Expression de cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer. 2002;31:147-54.
21. Öhd JF, Nielsen CH, Campbell J, Landberg G, Löfberg H, Sjölander A. Expression of the leukotriene D4 receptor CysLT1, COX-2 and other cell survival factors in colorectal adenocarcinomas. Gastroenterology. 2003;124:57-70.
22. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol. 2002;97:1037-41.